UK markets closed

NIKKEI 225
39,103.22
+486.12(+1.26%)
HANG SENG
18,868.71
-326.89(-1.70%)
CRUDE OIL
76.89
-0.68(-0.88%)
GOLD FUTURES
2,333.80
-59.10(-2.47%)
DOW
39,065.26
-605.78(-1.53%)
Bitcoin GBP
52,386.70
-2,558.30(-4.66%)

What does the UK general election mean for your finances?

Implications of a snap election on your pensions, savings, tax and investments

BCRX Sep 2024 6.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.2400

-0.2100

(-14.48%)

As of 01:59PM EDT. Market open.

Loading interactive chart…

GuruFocus.com
Insider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
Helen Thackray, Chief Research & Development Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 14, 2024.
GuruFocus.com
Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
On May 13, 2024, Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 21,940 shares of the company, as reported in a recent SEC Filing.
GuruFocus.com
Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
Charles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 13, 2024.